Applying Treatment Algorithms in Schizophrenia

Take this course to learn important updates on the pathophysiology, diagnosis, evidence-based treatment algorithms, and monitoring parameters to embrace the pharmacist’s role in managing patients with schizophrenia. Upon successful completion of this application-based CPE course, pharmacists should be able to: 1. List the signs, symptoms, and diagnostic criteria of schizophrenia. 2. Apply guideline-based treatment algorithms to persons with schizophrenia. 3. Develop monitoring plans for persons with schizophrenia and medications used to treat schizophrenia. 4. Formulate evidence-based recommendations for persons with schizophrenia. 5. Discuss the role of the pharmacy team in the patient journey for persons with schizophrenia. Hannah Johnson, PharmD, BCPS, BCPP Clinical Assistant Professor University of Kentucky College of Pharmacy Dr. Johnson has no relevant financial relationships with ineligible companies to disclose. Course fee includes course, course materials, and CPE credit submission to CPE Monitor. Course is non-refundable. Initial Release Date: May 1, 2026 Planned Expiration Date: May 1, 2029 Copyright 2026, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden. Universal Activity Number (UAN): 0107-0000-26-191-H01-P Application-based CPE Activity Release Date: April 29, 2026 Planned Expiration Date: April 30, 2029 CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net. ¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.